ReviewMolecular biology reports2026
Lysyl oxidase (LOX) family proteins in extracellular matrix homeostasis: roles in disease and radiation-induced pathogenesis.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The extracellular matrix (ECM) not only provides structural support in tissues but also regulates cellular processes and tissue homeostasis. The lysyl oxidase (LOX) family of enzymes, consisting of LOX and lysyl oxidase-like enzymes (LOXL1-4), is involved in ECM remodeling by catalyzing the crosslinking of collagen and elastin. Dysregulation of these enzymes is implicated in the pathogenesis of various diseases, including organ fibrosis and tumor development. Furthermore, LOX family members have been shown to affect radiotherapy responses, with specific involvement in radioresistance and radiation-induced fibrosis. This review summarizes the structural and functional characteristics of the LOX family, highlighting their roles in fibrotic diseases such as pulmonary fibrosis, liver fibrosis, and cardiac diseases, their roles in tumor progression, relevance in radiotherapy, and treatment targeting LOX and LOXLs. Understanding the underlying mechanisms and potential therapies is critical for developing novel strategies in both disease identification and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.